Literature DB >> 18798069

Effect of RNA interference of iASPP on the apoptosis in MCF-7 breast cancer cells.

Ze-Jun Liu1, Yun Cai, Lu Hou, Xing Gao, Hai-Ming Xin, Xin Lu, Shan Zhong, Shou-Zhi Gu, Jie Chen.   

Abstract

ASPP family is proved to be apoptotic specific regulators of p53. Among them, iASPP acts as an inhibitor of p53. To investigate the effect of the iASPP RNAi on the apoptosis of breast cancer cell MCF-7, we transfected the recombinant plasmid PGCsilencer H1/Neo/GFP/RNAi into MCF-7. The iASPP expression was analyzed by RT-PCR and Western blot. The cell apoptosis was detected by FCM. The results show that the expression of iASPP is descended and the apoptosis rate is increased after transfection. Therefore, we conclude that inhibition of expression of iASPP may resume the ability of p53 to induce apoptosis in MCF-7 cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18798069     DOI: 10.1080/07357900801965042

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  18 in total

1.  RNA interference-mediated silencing of iASPP induces cell proliferation inhibition and G0/G1 cell cycle arrest in U251 human glioblastoma cells.

Authors:  Guilin Li; Renzhi Wang; Jun Gao; Kan Deng; Junji Wei; Yanping Wei
Journal:  Mol Cell Biochem       Date:  2010-12-24       Impact factor: 3.396

2.  Increased expression of iASPP correlates with poor prognosis in FIGO IA2-IIA cervical adenocarcinoma following a curative resection.

Authors:  Fanming Kong; Xiaofeng Shi; Huzi Li; Pu Li; Jianchun Yu; XiaoJiang Li; Jun Chen; Yiyu Sun; Yingjie Jia
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

3.  Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.

Authors:  Zhengzheng Liu; Xin Zhang; Donghai Huang; Yong Liu; Xiaozhe Zhang; Lijun Liu; Guo Li; Yaozhang Dai; Haolei Tan; Jianyun Xiao; Yongquan Tian
Journal:  Med Oncol       Date:  2012-07-20       Impact factor: 3.064

4.  In vitro effect of iASPP on cell growth of oral tongue squamous cell carcinoma.

Authors:  Yu Chen; Wangxiang Yan; Shuqi He; Jiechun Chen; Dan Chen; Zhaoqiang Zhang; Zhiguo Liu; Xueqiang Ding; Anxun Wang
Journal:  Chin J Cancer Res       Date:  2014-08       Impact factor: 5.087

5.  Overexpression of iASPP-SV in glioma is associated with poor prognosis by promoting cell viability and antagonizing apoptosis.

Authors:  Xiangrong Liu; Jun Kang; Fang Liu; Shaohong Wen; Xianwei Zeng; Kuan Liu; Yumin Luo; Xunming Ji; Shangfeng Zhao
Journal:  Tumour Biol       Date:  2015-12-01

6.  MicroRNA124 regulate cell growth of prostate cancer cells by targeting iASPP.

Authors:  Jun Chen; Hengjun Xiao; Zhansen Huang; Zhiming Hu; Tao Qi; Bin Zhang; Xin Tao; Song-Hao Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

7.  Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells.

Authors:  Zhang-Zhi Hu; Benjamin L Kagan; Eric A Ariazi; Dean S Rosenthal; Lihua Zhang; Jordan V Li; Hongzhan Huang; Cathy Wu; V Craig Jordan; Anna T Riegel; Anton Wellstein
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

8.  iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway.

Authors:  Jinfeng Chen; Fei Xie; Lijian Zhang; Wen G Jiang
Journal:  BMC Cancer       Date:  2010-12-30       Impact factor: 4.430

9.  Downregulation of inhibitor of apoptosis‑stimulating protein of p53 inhibits proliferation and promotes apoptosis of gastric cancer cells.

Authors:  Lu-Lu Wang; Zhong Xu; Yang Peng; Lu-Chun Li; Xiao-Ling Wu
Journal:  Mol Med Rep       Date:  2015-04-01       Impact factor: 2.952

10.  Inhibitor of apoptosis-stimulating protein of p53 (iASPP) is required for neuronal survival after axonal injury.

Authors:  Ariel M Wilson; Vince A Chiodo; Sanford L Boye; Nicholas C Brecha; William W Hauswirth; Adriana Di Polo
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.